73
Neuromod Devices Ltd., an Irish medical device company specialising in tinnitus, has successfully closed a 10 million EUR equity financing to expand the availability of its tinnitus treatment device, Lenire.
Neuromod has raised 10 million EUR of equity in an expansion of its Series B fundraisings. The financing was oversubscribed and was led by existing investors Fountain Healthcare Partners and Panakès Partners, backing Neuromod’s mission to advance tinnitus care for patients globally.
Neuromod has been making Lenire available through audiology and ENT practices throughout the USA and Europe. Proceeds from the financing will be used to meet demand for Lenire through sustainable commercial expansion in the USA and…